Haemonetics Corporation
Haemonetics Corporation (HAE) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · HAE · as of Sep 30, 2025
Ownership Breakdown
316
Institutional Holders
▲ 1 vs Q2
$2.50B
Total Inst. Value
▼ $1.55B vs Q2
45.45M
Shares Outstanding
freeFloat 98.76%
51.32M
13F Shares Held
▼ 3.19M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
HAE largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK, INC. surgical & medical instruments & apparatus | 6.02M | 12.51% | 12.51% | $293.45B | Nov 12, 2025 | ▼ 344.1K |
VANGUARD GROUP INC surgical & medical instruments & apparatus | 4.83M | 10.05% | 10.05% | $235.64B | Nov 7, 2025 | ▼ 118.7K |
NEUBERGER BERMAN GROUP LLC surgical & medical instruments & apparatus | 3.67M | 7.63% | 7.63% | $178.87B | Nov 12, 2025 | ▼ 607.2K |
AQR CAPITAL MANAGEMENT LLC surgical & medical instruments & apparatus | 2.13M | 4.42% | 4.42% | $102.81B | Nov 14, 2025 | ▲ 1.68M |
STATE STREET CORP surgical & medical instruments & apparatus | 1.80M | 3.74% | 3.74% | $87.77B | Nov 14, 2025 | ▼ 83.3K |
RIVER ROAD ASSET MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.65M | 3.44% | 3.44% | $80.65B | Nov 12, 2025 | ▼ 886 |
UBS GROUP AG surgical & medical instruments & apparatus | 1.45M | 3.02% | 3.02% | $70.80B | Nov 13, 2025 | ▲ 582.8K |
ROYAL BANK OF CANADA surgical & medical instruments & apparatus | 1.26M | 2.62% | 2.62% | $61.45B | Nov 14, 2025 | ▲ 169.3K |
FMR LLC surgical & medical instruments & apparatus | 1.22M | 2.53% | 2.53% | $59.26B | Nov 13, 2025 | ▲ 380.0K |
GEODE CAPITAL MANAGEMENT, LLC surgical & medical instruments & apparatus | 1.20M | 2.50% | 2.50% | $58.66B | Nov 12, 2025 | ▼ 41.2K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
24
Increased
+5.83M shares3
New Positions
first time holders23
Decreased
−5.68M shares0
Sold Out
fully exitedNet shares change (top 50)
+147.6K
+5.83M / −5.68M
Net new holders
+4
3 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
HAE insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
1
Buy transactions
1
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Basil Michelle L EVP and General Counsel | May 15, 2026 | Award | 28,424 | — | — | 68.8K | Form 4 ↗ |
Basil Michelle L EVP and General Counsel | May 15, 2026 | Tax Withhold | 2,913 | $56.29 | $164.0K | 40.4K | Form 4 ↗ |
Chan Frank EVP, Chief Operating Officer | May 15, 2026 | Award | 27,535 | — | — | 32.9K | Form 4 ↗ |
Chan Frank EVP, Chief Operating Officer | May 15, 2026 | Tax Withhold | 546 | $56.29 | $30.7K | 5.4K | Form 4 ↗ |
DArecca James EVP, Chief Financial Officer | May 15, 2026 | Award | 29,312 | — | — | 54.4K | Form 4 ↗ |
DArecca James EVP, Chief Financial Officer | May 15, 2026 | Tax Withhold | 2,505 | $56.29 | $141.0K | 25.1K | Form 4 ↗ |
Maunsell Farris Maryanne VP, Chief Accounting Officer | May 15, 2026 | Award | 2,220 | — | — | 6.5K | Form 4 ↗ |
Maunsell Farris Maryanne VP, Chief Accounting Officer | May 15, 2026 | Tax Withhold | 197 | $56.29 | $11.1K | 4.3K | Form 4 ↗ |
Galvin Roy EVP, Chief Commercial Officer | May 15, 2026 | Award | 27,535 | — | — | 39.9K | Form 4 ↗ |
Galvin Roy EVP, Chief Commercial Officer | May 15, 2026 | Tax Withhold | 879 | $56.29 | $49.5K | 12.3K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Haemonetics Corporation (HAE) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 1.24%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Haemonetics Corporation is BLACKROCK, INC., holding approximately 6.02 million shares — equal to 12.51% of outstanding shares — as of September 30, 2025.
A total of 316 institutional investors currently hold HAE stock, with a combined institutional value of approximately $2.50 billion as of the most recent 13F filing period.
Frequently asked questions
HAE ownershipHaemonetics Corporation (HAE) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is BLACKROCK, INC. with a 12.51% stake. Company insiders hold 1.24%. Data sourced from SEC Form 13F as of September 30, 2025.